Birchview Capital, LP - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 85 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$385,200
+7.0%
40,0000.0%0.33%
+21.5%
Q2 2023$360,000
+114549.7%
40,0000.0%0.27%
+9.8%
Q1 2023$314
+16.3%
40,0000.0%0.25%
+28.8%
Q4 2022$270
-100.0%
40,0000.0%0.19%
-53.2%
Q3 2022$580,000
+47.2%
40,0000.0%0.41%
+42.2%
Q2 2022$394,000
-33.2%
40,0000.0%0.29%
-32.5%
Q1 2022$590,000
+11.5%
40,0000.0%0.42%
+24.6%
Q4 2021$529,000
-24.2%
40,0000.0%0.34%
-28.2%
Q3 2021$698,000
-27.1%
40,0000.0%0.48%
-17.1%
Q2 2021$958,000
-6.8%
40,0000.0%0.57%
-6.1%
Q1 2021$1,028,000
+80.4%
40,000
+33.3%
0.61%
+86.0%
Q4 2020$570,000
-24.6%
30,000
-50.0%
0.33%
+29.6%
Q3 2020$756,000
+108.3%
60,000
+100.0%
0.25%
+15.5%
Q2 2020$363,000
+57.8%
30,0000.0%0.22%
+7.4%
Q1 2020$230,000
-56.9%
30,0000.0%0.20%
-47.4%
Q4 2019$534,000
+53.4%
30,0000.0%0.39%
+67.2%
Q3 2019$348,00030,0000.23%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,719,576$25,679,00012.37%
Vivo Capital, LLC 1,618,296$30,731,0001.37%
Opaleye Management Inc. 470,203$8,929,0001.17%
INTERWEST VENTURE MANAGEMENT CO 388,766$7,383,0000.92%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 177,433$3,369,0000.92%
Ikarian Capital, LLC 1,063,961$20,204,0000.89%
Ghost Tree Capital, LLC 200,000$3,798,0000.85%
Logos Global Management LP 490,000$9,305,0000.80%
Eventide Asset Management 1,680,000$31,903,0000.49%
Affinity Asset Advisors, LLC 45,000$855,0000.45%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders